CAS: 1380716-06-2
![N-(4-Ethynylphenyl)-5,7-dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxamide](https://static.cymitquimica.com/products/IN/thumb/DA01BGMA.jpg)
N-(4-Ethynylphenyl)-5,7-dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxamide
CAS:1380716-06-2
Fórmula:
C17H14N4O
Pureza:
95%
Forma y color:
Solid
Peso molecular:
290.3193
Ref: IN-DA01BGMA
| 25mg | 162,00 € | ||
| 50mg | 273,00 € | ||
| 100mg | 614,00 € | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
ML198
CAS:1380716-06-2
ML198: Activates & chaperones glucocerebrosidase; a potential Gaucher disease treatment lead.
Fórmula:
C17H14N4O
Pureza:
98.31%
Forma y color:
Solid
Peso molecular:
290.32
Ref: TM-T8986
| 2mg | 48,00 € | ||
| 5mg | 94,00 € | ||
| 10mg | 128,00 € | ||
| 25mg | 248,00 € | ||
| 50mg | 371,00 € | ||
| 100mg | 551,00 € | ||
| 200mg | 728,00 € |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
![N-(4-Ethynylphenyl)-5,7-dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxamide](https://static.cymitquimica.com/products/TR/thumb/E932345.jpg)
N-(4-Ethynylphenyl)-5,7-dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxamide
Producto controladoCAS:1380716-06-2
Fórmula:
C17H14N4O
Forma y color:
Neat
Peso molecular:
290.319
Ref: TR-E932345
| 25mg | 1.049,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
![N-(4-Ethynylphenyl)-5,7-dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxamide](https://static.cymitquimica.com/products/3D/thumb/FFC71606.jpg)
N-(4-Ethynylphenyl)-5,7-dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxamide
CAS:1380716-06-2
Versatile small molecule scaffold
Fórmula:
C17H14N4O
Pureza:
Min. 95%
Peso molecular:
290.32 g/mol
Ref: 3D-FFC71606
| 25mg | 188,00 € | ||
| 250mg | 746,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
